The genus *Ebolavirus* comprises 5 virus species: *Zaire ebolavirus* (EBOV), *Sudan ebolavirus* (SUDV), *Bundibugyo* *ebolavirus* (BDBV), *Taï Forest* *ebolavirus* (TAFV), and *Reston ebolavirus* (RESTV). The genus *Marburgvirus* comprises 1 species, *Marburg marburgvirus*, which includes 2 closely related virus strains: Marburg virus (MARV) and Ravn virus (RAVV). Viruses within the *Ebolavirus* and *Marburgvirus* genera are zoonotic; EBOV was the causative agent of the 2014--2016 Ebola virus disease epidemic in West Africa ([@R1]). *Rousettus* bats in Africa have been identified as *Marburgvirus* hosts ([@R2]), and viral nucleic acid and serologic evidence suggests that bats are also natural hosts of*Ebolavirus* spp. ([@R3]). Yet it remains unclear which species are the definitive reservoirs of filoviruses.

Ecologic models of *Ebolavirus* and *Marburgvirus* geographic distribution and habitat ranges of potential reservoir bat species suggest that both groups are distributed throughout Asia ([@R3],[@R4]). Serologic evidence of filoviruses in frugivorous bats in Bangladesh, China, and the Philippines has been reported ([@R5]--[@R7]), and RESTV nucleic acid was detected in an insectivorous bat in the Philippines, where RESTV is considered endemic ([@R8]). We examined pteropodid bats of 3 species: *Cynopterus brachyotis*, *Eonycteris spelaea*, and *Penthetor lucasi*, which are widely distributed across Southeast Asia and share ecologic niches ([@R9]).

The Study
=========

During 2011--2016, we collected serum from bats of the 3 aforementioned species in Singapore and screened samples for evidence of exposure to filoviruses. Samples were collected with permission from the National University of Singapore Institutional Animal Care and Use Committee (B01/12) and the National Parks Board (NP/RP11--011--3a). We diluted venous blood 1:10 in phosphate-buffered saline and then centrifuged, recovered, and heat-inactivated the serum at 56°C for 30 minutes and stored it at −80°C.

We developed a Bio-Plex (Bio-Rad, Hercules, CA, USA) bead-based multiplex assay that simultaneously probes serum for immunoglobulins specific to the viral envelope glycoproteins (GPs) from representative strains of all described *Ebolavirus* and *Marburgvirus* species ([Table 1](#T1){ref-type="table"}). A human FreeStyle 293-F stable cell-line expression system was used to produce the *Ebolavirus* and *Marburgvirus* spp. GPs as a soluble GP consisting of the entire ectodomain, sGP~(1,2)~, which retains a native-like oligomeric conformation, as described previously with modifications ([@R10]). In brief, each GP~(1,2)~ coding sequence was truncated at the C-terminus to remove the predicted transmembrane domain and cytoplasmic tail, then appended with the GCN trimerization peptide sequence ([@R10]) together with a factor Xa protease cleave site and a Twin-Strep-tag sequence (IBA Lifesciences, Göttingen, Germany). The sGP~(1,2)~ proteins were produced in serum-free conditions and purified by Strep-Tactin XT technology (IBA Lifesciences). The Twin-Strep-tag was removed by factor Xa enzymatic cleavage; factor Xa was removed by Xarrest Agarose (Merck Millipore, Billerica, MA, USA); sGP~(1,2)~ was purified further by S-200 size exclusion chromatography, concentrated, and stored frozen. These sGP~(1,2)~s were coupled to carboxylated beads (Bio-Rad). Screening was performed on a Bio-Rad Bio-Plex 200.

###### *Ebolavirus* and *Marburgvirus* species soluble envelope glycoproteins conjugated Bio-Plex beads used in multiplex assay to detect antibodies against filoviruses\*

  Virus                                                Isolation host/location   Bio-Plex bead no.   NCBI accession no.
  ---------------------------------------------------- ------------------------- ------------------- --------------------
  Ebola virus/H.sapiens/COD/1976/Yambuku-Mayinga       Human/DRC                 33                  NC_002549.1
  Bundibugyo virus/H. sapiens/UGA/2007                 Human/Uganda              64                  FJ217161.1
  Taï Forest virus/H. sapiens/COV/1994/Pauleoula-CI    Human/Côte d\'Ivoire      57                  NC_014372
  Sudan virus/H. sapiens/UGA/2000/Gulu-808892          Human/Uganda              77                  NC_006432.1
  Reston virus/M. fascicularis/USA/1989/Pennsylvania   Macaque/USA               85                  AF522874.1
  Reston virus/S. domesticus/PHL/2008/Reston08-A       Swine/Philippines         72                  FJ621583.1
  Marburg virus/H. sapiens/KEN/1980/Musoke             Human/Kenya               37                  Z12132 S55429
  Marburg virus/H. sapiens/AGO/2005/Ang0126            Human/Angola              28                  DQ447656.1
  Ravn virus/H. sapiens/KEN/1987/Kitum cave-810040     Human/Kenya               49                  NC_024781.1

\*Bio-Plex manufactured by Bio-Rad (Hercules, CA, USA). DRC, Democratic Republic of the Congo; NCBI, National Center for Biotechnology Information.

In the absence of confirmed filovirus-negative bat serum, we used methods developed by Peel et al. to establish a median fluorescence intensity (MFI) cutoff value ([@R11]). We confirmed a cutoff value of 200 MFI ([Technical Appendix](#SD1){ref-type="local-data"}), as was previously used for *Eidolon helvum* bat serum in a Bio-Plex serologic assay ([@R12]). We screened 409 samples with our *Ebolavirus* and *Marburgvirus* spp. sGP~(1,2)~ Bio-Plex assay modified from that described by Bossart et al. ([@R13]). Samples were diluted 1:100 and tested in duplicate; the sGP~(1,2)~-coupled beads were mixed with individual samples; and a 1:1 combination of recombinant biotinylated-protein A/protein G (1:500) (Pierce, Rockford, IL, USA) was added to the wells, followed by addition of streptavidin-phycoerythrin (1:1,000) (Bio-Rad) and determination of MFI.

Samples were positive for 17 (9.1%) of 186 *E. spelaea*, 13 (8.5%) of 153 *C. brachyotis*, and 3 (4.3%) of 70 *P. lucasi* bats ([Figure 1](#F1){ref-type="fig"}). Positive samples reacted with EBOV, BDBV, SUDV, or TAFV sGP~(1,2)~. However, no samples were positive for RESTV, MARV, or RAVV sGP~(1,2)~. We further examined positive samples to determine cross-reactivity between the *Ebolavirus* spp. sGP~(1,2)~ ([Table 2](#T2){ref-type="table"}). Twelve (71%) samples from *E. spelaea* bats cross-reacted with [\>]{.ul}2 *Ebolavirus* spp. sGP~(1,2)~ (BDBV, EBOV, SUDV, or TAFV). In contrast, 8 (62%) *C. brachyotis* and 2 (66%) *P. lucasi* samples were positive for only 1 sGP~(1,2)~ (BDBV or SUDV).

![Mean fluorescence intensity (MFI) values obtained from Bio-Plex assay (Bio-Rad, Hercules, CA, USA) screening of individual serum samples from bats of 3 species with soluble filovirus glycoproteins. Dashed line indicates the cutoff value at 200 MFI. 1, *Zaire ebolavirus*; 2, *Bundibugyo ebolavirus*; 3, *Taï Forest ebolavirus*; 4, *Sudan ebolavirus*; 5, *Reston ebolavirus*--monkey; 6, *Reston ebolavirus*--pig; 7, Marburg virus--Musoke; 8, Marburg virus--Angola; 9, Ravn virus.](17-0401-F1){#F1}

###### Bio-Plex median fluorescence intensity values for bat serum positive for [\>]{.ul}1 filovirus antigen\*

  Bat species, ID                    EBOV       BDBV      TAFV      SUDV      RESTVm   RESTVp   MARV(Mus)   MARV(Ang)   RAVV
  ---------------------------------- ---------- --------- --------- --------- -------- -------- ----------- ----------- ------
  *Eonycteris spelaea*, n = 186                                                                                         
  0805149†                           **738**    124       68        40        44       22       23          21          24
  080814                             86         **318**   105       **258**   26       12       17          16          20
  082154                             143        161       113       **214**   35       41       21          31          39
  052313                             **284**    **408**   177       **285**   89       72       29          23          30
  052335                             **203**    191       124       **219**   42       21       38          38          24
  052339                             **357**    **306**   141       **293**   54       31       26          26          42
  071839                             **330**    **299**   164       **480**   65       44       28          33          45
  071842                             **446**    **327**   **202**   **362**   65       49       42          38          57
  110733                             126        **416**   166       95        58       42       34          42          58
  011603†                            **1151**   130       91        69        36       32       51          35          39
  011616                             **252**    294       168       175       32       49       47          29          50
  011656                             **306**    **386**   **204**   **394**   89       73       18          39          37
  012309†                            **579**    **659**   **315**   69        35       31       27          33          35
  021303                             **478**    **431**   188       **450**   52       37       24          30          47
  111903                             **469**    **384**   **276**   113       52       57       37          69          54
  111907                             **285**    **336**   **213**   158       39       36       29          50          30
  042722                             **260**    **262**   174       **1**67   75       31       54          24          42
  *Cynopterus brachyotis*, n = 153                                                                                      
  051253                             121        133       59        **242**   40       41       19          25          68
  0516613                            146        **293**   127       73        47       36       25          29          22
  0516632                            138        139       86        **356**   35       25       28          34          34
  0726122†                           119        **501**   100       60        40       46       25          19          29
  1103241                            84         141       128       **241**   50       47       66          38          34
  100903                             148        **201**   71        108       42       33       18          16          36
  100914                             74         **228**   70        55        39       38       30          27          26
  100925                             166        **304**   109       116       43       18       33          30          28
  021357                             **201**    **299**   179       **264**   65       44       25          55          47
  050804                             **242**    **276**   140       124       41       30       34          33          44
  050818                             **383**    **374**   198       **332**   60       55       29          26          68
  040807†                            **297**    **597**   194       192       40       38       122         95          32
  042701†                            **339**    **547**   **222**   **417**   60       78       54          25          62
  *Penthetor lucasi*, n = 70                                                                                            
  062590†                            34         **496**   93        39        36       18       23          17          23
  070409†                            95         **238**   129       89        62       27       34          36          37
  112112†                            **251**    **352**   148       **235**   51       29       23          23          29

\*Bio-Plex manufactured by Bio-Rad (Hercules, CA, USA). Boldface indicates positive results. BDBV, Bundibugyo virus; EBOV, Ebola virus; ID, specimen identification number; MARV(Mus), Marburg virus--Musoke; MARV(Ang), Marburg virus--Angola; RESTVm, Reston virus--monkey; RESTVp, Reston virus--pig; SUDV, Sudan virus; RAVV, Ravn virus; TAFV, Taï Forest virus.  †Sample screened by Western blot and shown in Figure 2.

To further determine the cross-reactivity of positive samples and to corroborate Bio-Plex assay results for a selected number of samples, we performed Western blot (WB) assays ([Figure 2](#F2){ref-type="fig"}). The filovirus GP~(1,2)~ is a trimer of heterodimeric GP~1~ and GP~2~ subunits. The trimeric-like sGP~(1,2)~ is the antigen in the multiplex Bio-Plex assay, whereas linearized monomeric sGP~1~ and sGP~2~ subunits are the antigens in WBs. Reduced and denatured EBOV or BDBV unconjugated sGP~(1,2)~ was loaded on 8% sodium dodecyl sulfate--polyacrylamide electrophoresis gels, transferred to a polyvinylidene difluoride membrane, and probed with 1:100 dilutions of positive and negative bat serum, as previously determined by the Bio-Plex assay. All 3 *E. spelaea* bat samples and 2 of 3 *C. brachyotis* bat samples that were Bio-Plex positive were also positive by WB and displayed reactivity with EBOV and BDBV GP~1~ and GP~2~ antigens; no *P. lucasi* bat samples positive by Bio-Plex were positive by WB.

![Western blot results of individual bat serum samples probed against *Zaire ebolavirus* and *Bundibugyo ebolavirus* glycoproteins 1 and 2 (GP~1~, GP~2~). Boldface indicates positivity by Western blot and underlining indicates positivity by Bio-Plex (Bio-Rad, Hercules, CA, USA). 1, soluble GP~1~ and GP~2~ blotted with control anti--Ebola virus nonhuman primate polyclonal serum that demonstrates cross-reactivity with *Bundibugyo ebolavirus* soluble GP. Other numbers along baseline correspond to the following sample identifiers, also used in [Table 2](#T2){ref-type="table"}: 2, 0805149; 3, 012309; 4, 011603; 5, 0116048; 6, 0719036; 7, 1128015; 8, 0726122; 9, 042701; 10, 040807; 11, 0512540; 12, 1009010; 13, 0408029; 14, 070409; 15, 112112; 16, 062590; 17, 0228004; 18, 0919025; 19, 0625095. BDBV, Bundibugyo virus; EBOV, Ebola virus.](17-0401-F2){#F2}

Conclusions
===========

We present evidence of antibodies specific to filoviruses antigenically related to *Ebolavirus* spp. in 3 species of fruit bats widely distributed throughout Southeast Asia. We detected seroreactivity with *Ebolavirus* spp. but not *Marburgvirus* spp. GP. Despite the close relatedness of the viruses, we detected samples reacting with only SUDV, not RESTV, GP. This finding contrasts with previous reports of bat serum cross-reactivity with RESTV nucleoprotein ([@R5],[@R7],[@R14]). Possible explanations include 1) the fact that our customized Bio-Plex assay is based on conformational sGP~(1,2)~, which can differentiate antibody specificity better than the more sequence conserved nucleoprotein, and 2) the lack of evidence of RESTV GP positivity with *Cynopterus* and *Eonycteris* bat serum samples, which is in line with previous findings (both species were negative while only *Rousettus amplexicaudatus* bats were positive) ([@R7]). *E. spelaea* bats were previously predicted to be filovirus hosts ([@R15]), and sequences of novel filoviruses have been discovered in *E. spelaea* bat populations in Yunnan, China ([@R14]). Our data provide additional empirical evidence that populations of *C. brachyotis, E. spelaea,* and *P. lucasi* bats in Southeast Asia are hosts of filoviruses, which seem antigenically more closely related to EBOV, BDBV, and SUDV than to RESTV.

Examination of cross-reactivity of positive samples from *E. spelaea, C. brachyotis,* and *P. lucasi* bats revealed no clear patterns of preferential reactivity with EBOV, BDBV, or SUDV GP. Factors that might contribute to the lack of *P. lucasi* positivity by WB include sensitivity differences between Bio-Plex and WB assays paired with the change in sGP~(1,2)~ conformation. Two Bio-Plex EBOV-positive samples (*E. spelaea* samples 0805149 and 011603) reacted with EBOV sGP~2~ and BDBV sGP~1~ in the WB. Bio-Plex and WB data strongly suggest the presence of yet-undetected batborne filoviruses, which are antigenically related to but distinct from BDBV, EBOV, and SUDV circulating in local bat populations. Reasons why these filoviruses have remained undetected include their inability to cross the species barrier, the rarity of spillovers into humans or domestic animals, or the fact that spillover events cause mild or no disease. We suggest that a yet-undescribed diversity of filoviruses exists in Southeast Asia bat populations, a hypothesis supported by the recent identification of filovirus sequences in *E. spelaea* and *R. leschenaulti* bats in China ([@R14],[@R16]). Comprehensive surveillance including serology and detection of viral nucleic acid, along with virus isolation, will help elucidate the characteristics of filoviruses endemic to Asia and identify bat species that function as maintenance populations and reservoirs.

###### Technical Appendix

Median fluorescence intensity cutoff value determination and results for filoviruses in serum from fruit bats, Singapore, 2011--2016.
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